新冠疫情期间与疫情前心理健康症状比较:134个队列的系统综述与Meta分析
该系统综述纳入134个队列的137项研究,比较新冠疫情期间与疫情前一般心理健康、焦虑和抑郁症状的变化。一般人群抑郁症状轻微加重(SMD变化0.12,95%CI 0.01至0.24),女性所有领域症状轻微至小幅加重;多数变化估计接近零且不显著,但存在实质异质性和偏倚风险。
要点
- 一般人群抑郁症状轻微加重(SMD变化0.12,95%CI 0.01至0.24),一般心理健康和焦虑症状无显著变化。
- 女性或女性参与者一般心理健康、焦虑和抑郁症状均轻微至小幅加重。
- 多数症状变化估计接近零且不显著,但研究间异质性和偏倚风险较大。
核心结论
- 许多研究存在高偏倚风险和实质异质性,提示解释结果需谨慎。
- 一般心理健康、焦虑和抑郁症状的大多数变化估计接近零且无统计学显著性,有统计学显著的变化幅度为轻微至小幅。
- 女性或女性参与者在所有结局领域均出现小幅负向变化。
- 作者将随着更多证据积累更新该系统综述结果,研究结果在线发布(https://www.depressd.ca/covid-19-mental-health)。
研究设计与样本
- 系统综述,检索Medline、PsycINFO、CINAHL、Embase、Web of Science、中国知网、万方、medRxiv和Open Science Framework Preprints。
- 纳入标准:比较2020年1月1日或之后评估的一般心理健康、焦虑症状或抑郁症状与2018年1月1日至2019年12月31日收集的结局,且同一参与者疫情前后占比≥90%或使用统计方法处理缺失数据。
- 截至2022年4月11日,共审查94 411条唯一标题和摘要,纳入来自134个队列的137项唯一研究。
- 大多数研究来自高收入国家(n=105,77%)或中高收入国家(n=28,20%)。
- 采用限制性最大似然随机效应Meta分析(新冠结局更差代表正向变化),使用改编的Joanna Briggs Institute患病率研究清单评估偏倚风险。
主要发现
- 一般人群研究中,一般心理健康无变化(SMD变化0.11,95%CI -0.00至0.22),焦虑症状无变化(0.05,-0.04至0.13),抑郁症状轻微加重(0.12,0.01至0.24)。
- 女性或女性参与者中,一般心理健康(0.22,0.08至0.35)、焦虑症状(0.20,0.12至0.29)和抑郁症状(0.22,0.05至0.40)轻微至小幅加重。
- 在女性或女性参与者以外亚组的27项其他分析中,5项分析提示症状轻微或小幅加重,2项提示轻微或小幅改善。
- 三项研究包含2020年3月至4月和2020年末的数据,症状在两次评估时均与新冠前水平无变化,或初期升高后回落至新冠前水平。
- 各项分析存在实质异质性和偏倚风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 许多研究存在高偏倚风险。
- 各项分析存在实质异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To synthesise results of mental health outcomes in cohorts before and during the covid-19 pandemic. DESIGN: Systematic review. DATA SOURCES: Medline, PsycINFO, CINAHL, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, medRxiv, and Open Science Framework Preprints. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Studies comparing general mental health, anxiety symptoms, or depression symptoms assessed from 1 January 2020 or later with outcomes collected from 1 January 2018 to 31 December 2019 in any population, and comprising ≥90% of the same participants before and during the covid-19 pandemic or using statistical methods to account for missing data. Restricted maximum likelihood random effects meta-analyses (worse covid-19 outcomes representing positive change) were performed. Risk of bias was assessed using an adapted Joanna Briggs Institute Checklist for Prevalence Studies. RESULTS: As of 11 April 2022, 94 411 unique titles and abstracts including 137 unique studies from 134 cohorts were reviewed. Most of the studies were from high income (n=105, 77%) or upper middle income (n=28, 20%) countries. Among general population studies, no changes were found for general mental health (standardised mean difference (SMD)change 0.11, 95% confidence interval -0.00 to 0.22) or anxiety symptoms (0.05, -0.04 to 0.13), but depression symptoms worsened minimally (0.12, 0.01 to 0.24). Among women or female participants, general mental health (0.22, 0.08 to 0.35), anxiety symptoms (0.20, 0.12 to 0.29), and depression symptoms (0.22, 0.05 to 0.40) worsened by minimal to small amounts. In 27 other analyses across outcome domains among subgroups other than women or female participants, five analyses suggested that symptoms worsened by minimal or small amounts, and two suggested minimal or small improvements. No other subgroup experienced changes across all outcome domains. In three studies with data from March to April 2020 and late 2020, symptoms were unchanged from pre-covid-19 levels at both assessments or increased initially then returned to pre-covid-19 levels. Substantial heterogeneity and risk of bias were present across analyses. CONCLUSIONS: High risk of bias in many studies and substantial heterogeneity suggest caution in interpreting results. Nonetheless, most symptom change estimates for general mental health, anxiety symptoms, and depression symptoms were close to zero and not statistically significant, and significant changes were of minimal to small magnitudes. Small negative changes occurred for women or female participants in all domains. The authors will update the results of this systematic review as more evidence accrues, with study results posted online (https://www.depressd.ca/covid-19-mental-health). REVIEW REGISTRATION: PROSPERO CRD42020179703.
引用
- Sun Y, Wu Y, Fan S, et al. Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts. BMJ. 2023. PMID: 36889797. doi:10.1136/bmj-2022-074224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。